-
公开(公告)号：US11890277B2
公开(公告)日：2024-02-06
申请号：US18055940
申请日：2022-11-16
申请人： Sydnexis, Inc.
CPC分类号： A61K31/46 , A61K9/0048 , A61K47/02
摘要： Provided herein is an ophthalmic composition. In some embodiments, the ophthalmic composition includes a low concentration of an ophthalmic agent for treatment of an ophthalmic disorder or condition; and an ophthalmically acceptable carrier, wherein the ophthalmic agent is distributed with substantial uniformity throughout the ophthalmically acceptable carrier. Further disclosed herein include an ophthalmic composition including a low concentration of an ophthalmic agent and deuterated water. Also disclosed herein are methods of arresting or preventing myopia development by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.
-
公开(公告)号：US11382909B2
公开(公告)日：2022-07-12
申请号：US16677538
申请日：2019-11-07
申请人： SYDNEXIS, INC.
摘要： Provided herein is an ophthalmic composition. In some embodiments, the ophthalmic composition includes a low concentration of an ophthalmic agent for treatment of an ophthalmic disorder or condition; and an ophthalmically acceptable carrier, wherein the ophthalmic agent is distributed with substantial uniformity throughout the ophthalmically acceptable carrier. Further disclosed herein include an ophthalmic composition including a low concentration of an ophthalmic agent and deuterated water. Also disclosed herein are methods of arresting or preventing myopia development by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.
-
公开(公告)号：US09770447B2
公开(公告)日：2017-09-26
申请号：US15208537
申请日：2016-07-12
申请人： Sydnexis, Inc.
CPC分类号： A61K31/46 , A61K9/0048 , A61K47/02
摘要： Provided herein is an ophthalmic composition. In some embodiments, the ophthalmic composition includes a low concentration of an ophthalmic agent for treatment of an ophthalmic disorder or condition; and an ophthalmically acceptable carrier, wherein the ophthalmic agent is distributed with substantial uniformity throughout the ophthalmically acceptable carrier. Further disclosed herein include an ophthalmic composition including a low concentration of an ophthalmic agent and deuterated water. Also disclosed herein are methods of arresting or preventing myopia development by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.
-
公开(公告)号：US11896588B2
公开(公告)日：2024-02-13
申请号：US18055945
申请日：2022-11-16
申请人： Sydnexis, Inc.
CPC分类号： A61K31/46 , A61K9/0048 , A61K47/02
摘要： Provided herein is an ophthalmic composition. In some embodiments, the ophthalmic composition includes a low concentration of an ophthalmic agent for treatment of an ophthalmic disorder or condition; and an ophthalmically acceptable carrier, Wherein the ophthalmic agent is distributed with substantial uniformity throughout the ophthalmically acceptable carrier. Further disclosed herein include an ophthalmic composition including a low concentration of an ophthalmic agent and deuterated water. Also disclosed herein are methods of arresting or preventing myopia development by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.
-
公开(公告)号：US11052094B2
公开(公告)日：2021-07-06
申请号：US15578202
申请日：2016-05-27
申请人： SYDNEXIS, INC.
IPC分类号： A61K31/5575 , A61K47/02 , A61K9/00 , A61K9/08 , A61K9/06 , A61P27/02 , A61K31/18 , A61K31/216 , A61K31/565 , A61K31/57 , A61K47/34 , A61K47/38
摘要： Provided herein is an ophthalmic composition formulated in deuterated water. Also disclosed herein are methods of treating, ameliorating, or reducing ophthalmic conditions or diseases by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.
-
公开(公告)号：US11883390B2
公开(公告)日：2024-01-30
申请号：US18055949
申请日：2022-11-16
申请人： Sydnexis, Inc.
CPC分类号： A61K31/46 , A61K9/0048 , A61K47/02
摘要： Provided herein is an ophthalmic composition. In some embodiments, the ophthalmic composition includes a low concentration of an ophthalmic agent for treatment of an ophthalmic disorder or condition; and an ophthalmically acceptable carrier, wherein the ophthalmic agent is distributed with substantial uniformity throughout the ophthalmically acceptable carrier. Further disclosed herein include an ophthalmic composition including a low concentration of an ophthalmic agent and deuterated water. Also disclosed herein are methods of arresting or preventing myopia development by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.
-
公开(公告)号：US20160009705A1
公开(公告)日：2016-01-14
申请号：US14859042
申请日：2015-09-18
申请人： Sydnexis, Inc.
IPC分类号： C07D451/10 , A61K9/00 , A61K31/46
CPC分类号： C07D451/10 , A61K9/0048 , A61K9/06 , A61K9/08 , A61K31/46 , A61K47/02 , A61K47/38
摘要： Provided herein is an ophthalmic composition. In some embodiments, the ophthalmic composition includes a low concentration of an ophthalmic agent for treatment of an ophthalmic disorder or condition; and an ophthalmically acceptable carrier, wherein the ophthalmic agent is distributed with substantial uniformity throughout the ophthalmically acceptable carrier. Further disclosed herein include an ophthalmic composition including a low concentration of an ophthalmic agent and deuterated water. Additionally disclosed herein include an ophthalmic composition including a low concentration of a deuterated ophthalmic agent. Also disclosed herein are methods of arresting or preventing myopia development by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.
摘要翻译： 本文提供的是眼用组合物。 在一些实施方案中，眼用组合物包含低浓度的用于治疗眼部疾病或病症的眼用药剂; 和眼科学上可接受的载体，其中眼用剂在整个眼科可接受的载体中分布均匀。 本文进一步公开的包括眼用组合物，其包含低浓度的眼用剂和氘代水。 本文另外公开的包括含有低浓度氘化眼药的眼用组合物。 本文还公开了通过向有需要的个体的眼睛施用有效量的本文所述的眼用组合物来阻止或防止近视发展的方法。
-
公开(公告)号：US20150366854A1
公开(公告)日：2015-12-24
申请号：US14726139
申请日：2015-05-29
申请人： Sydnexis, Inc.
CPC分类号： A61K31/46 , A61K9/0048 , A61K47/02
摘要： Provided herein is an ophthalmic composition. In some embodiments, the ophthalmic composition includes a low concentration of an ophthalmic agent for treatment of an ophthalmic disorder or condition; and an ophthalmically acceptable carrier, wherein the ophthalmic agent is distributed with substantial uniformity throughout the ophthalmically acceptable carrier. Further disclosed herein include an ophthalmic composition including a low concentration of an ophthalmic agent and deuterated water. Also disclosed herein are methods of arresting or preventing myopia development by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.
摘要翻译： 本文提供的是眼用组合物。 在一些实施方案中，眼用组合物包含低浓度的用于治疗眼部疾病或病症的眼用药剂; 和眼科学上可接受的载体，其中眼用剂在整个眼科可接受的载体中分布均匀。 本文进一步公开的包括眼用组合物，其包含低浓度的眼用剂和氘代水。 本文还公开了通过向有需要的个体的眼睛施用有效量的本文所述的眼用组合物来阻止或防止近视发展的方法。
-
公开(公告)号：US10953002B2
公开(公告)日：2021-03-23
申请号：US16785416
申请日：2020-02-07
申请人： SYDNEXIS, INC.
摘要： Provided herein is an ophthalmic composition. In some embodiments, the ophthalmic composition includes a low concentration of an ophthalmic agent for treatment of an ophthalmic disorder or condition; and an ophthalmically acceptable carrier, wherein the ophthalmic agent is distributed with substantial uniformity throughout the ophthalmically acceptable carrier. Further disclosed herein include an ophthalmic composition including a low concentration of an ophthalmic agent and deuterated water. Also disclosed herein are methods of arresting or preventing myopia development by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.
-
公开(公告)号：US10940145B2
公开(公告)日：2021-03-09
申请号：US16785418
申请日：2020-02-07
申请人： SYDNEXIS, INC.
摘要： Provided herein is an ophthalmic composition. In some embodiments, the ophthalmic composition includes a low concentration of an ophthalmic agent for treatment of an ophthalmic disorder or condition; and an ophthalmically acceptable carrier, wherein the ophthalmic agent is distributed with substantial uniformity throughout the ophthalmically acceptable carrier. Further disclosed herein include an ophthalmic composition including a low concentration of an ophthalmic agent and deuterated water. Also disclosed herein are methods of arresting or preventing myopia development by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.
-
-
-
-
-
-
-
-
-
搜索结果
18 条记录 (耗时 0.019 秒)
